The role of varicella zoster virus immediate-early proteins in latency and their potential use as components of vaccines
Varicella zoster virus im-early (IE) proteins are intracellular regulators of viral gene expression. Some of them (1E62 and 1E63) are found in large amounts in infected cells but are also components of the virion tegument. Several IE and early genes are transcribed during latency, while late genes are not. Recently, we demonstrated the presence of protein IE 63 in dorsal root ganglia of persistently infected rats as well as in normal human ganglia; other IE proteins have been found since in human ganglia. Cell-mediated immunity (CMI) to IE 62 has been evidenced. We found both humoral immunity and CMI to IE 63 in immune adults. In elderly zoster-free individuals, CMI to IE 63 remained high. The differences in the CMI to IE 63 among young adults, elderly people and immunocompromized patients have to be analyzed according to their status relative to zoster, to determine whether the decrease in CMI, particularly to IE proteins, could be responsible for viral reactivation and for the onset of shingles. Hopefully, the waning of the CMI to VZV IE 63 and perhaps to other IE proteins could become a predictive marker for herpes zoster and reimmunization, not only with the vaccine strain, but also with purified IE proteins could help prevent zoster at old age.
KeywordsHerpes Zoster Varicella Zoster Virus Viral Reactivation Viral Tegument Human Trigeminal Ganglion
Unable to display preview. Download preview PDF.
- 6.Berger R, Florent G, Just M (1980) Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infect Immun 32: 24–27Google Scholar
- 10.Cohrs RJ, Srock K, Barbour MB, Owens G, Mahalingam R, Devlin ME, Wellish M, Gilden DH (1994) Varicella-zoster virus (VZV) transcription during latency in human ganglia: construction of a cDNA library from latently infected human trigeminal ganglia and detection of a VZV transcript. J Virol 68: 7900–7908PubMedGoogle Scholar
- 25.Levin MJ, Barber D, Goldblatt E, Jones M, LaFleur B, Chan C, Stinson D, Zerbe GO, Hayward AR (1998) Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis 178 [Suppl 1]: S109—S112PubMedCrossRefGoogle Scholar
- 34.Nikkels AF, Debrus S, Sadzot-Delvaux C, Piette J, Rentier B, Pierard GE (1995) Immunohistochemical identification of varicella-zoster virus gene 63-encoded protein (1E63) and late (gE) protein on smears and cutaneous biopsies: implications for diagnostic use. J Med Virol 47: 342–347PubMedCrossRefGoogle Scholar
- 36.Pereira RA, Tscharke DC, Simmons A (1994) Upregulation of class I major histocompatibility complex gene expression in primary sensory neurons, satellite cells, and Schwann cells of mice in response to acute but not latent herpes simplex virus infection in vivo. J Exp Med 180: 841–850PubMedCrossRefGoogle Scholar
- 44.Whitley RJ (1996) Herpes simplex virus. In: Fields BN, Knipe DM, Howley PM (eds) Virology. Lippincott-Raven, New York, pp 2297–2342Google Scholar